Bristol-Myers Squibb CompanyBMYNYSE
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+11.0%
5Y CAGR+23.1%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+11.0%/yr
vs +9.7%/yr prior
5Y CAGR
+23.1%/yr
Recent deceleration
Acceleration
+1.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $12.70B | +31.5% |
| 2024 | $9.66B | +14.0% |
| 2023 | $8.47B | -8.6% |
| 2022 | $9.27B | -2.8% |
| 2021 | $9.54B | +112.4% |
| 2020 | $4.49B | -30.2% |
| 2019 | $6.44B | +0.7% |
| 2018 | $6.39B | +22.0% |
| 2017 | $5.24B | +1.2% |
| 2016 | $5.18B | - |